Robuta

https://pubmed.ncbi.nlm.nih.gov/29750338/
Our data suggest that a longer CIM use in the first 5 years of disease can have negative effects on cognitive outcome in Dravet syndrome. An early diagnosis is...
contraindicated medicationinfluenceusecognitiveoutcome